Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
JAKed up phenotype of CEBPA-mutant AML
Jeffrey W. Tyner
Knight Cancer Institute
Knight Cancer Translational Oncology Program
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'JAKed up phenotype of CEBPA-mutant AML'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Genetic Association Studies
100%
Acute Myeloid Leukemia
89%
Phenotype
56%